Cardiovascular adverse events associated with smoking-cessation pharmacotherapies
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F15%3A00061298" target="_blank" >RIV/00159816:_____/15:00061298 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1007/s11886-014-0554-8" target="_blank" >http://dx.doi.org/10.1007/s11886-014-0554-8</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s11886-014-0554-8" target="_blank" >10.1007/s11886-014-0554-8</a>
Alternative languages
Result language
angličtina
Original language name
Cardiovascular adverse events associated with smoking-cessation pharmacotherapies
Original language description
Smoking continues to be the leading cause of preventable deaths in the USA, accounting for one in every five deaths every year, and cardiovascular (CV) disease remains the leading cause of those deaths. Hence, there is increasing awareness to quit smoking among the public and counseling plays an important role in smoking cessation. There are different pharmacological methods to help quit smoking that includes nicotine replacement products available over the counter, including patch, gum, and lozenges, to prescription medications, such as bupropion and varenicline. There have been reports of both nonserious and serious adverse CV events associated with the use of these different pharmacological methods, especially varenicline, which has been gaining media attention recently. Therefore, we systematically reviewed the various pharmacotherapies used in smoking cessation and analyzed the evidence behind these CV events reported with these therapeutic agents.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Current Cardiology Reports
ISSN
1523-3782
e-ISSN
—
Volume of the periodical
17
Issue of the periodical within the volume
1
Country of publishing house
US - UNITED STATES
Number of pages
7
Pages from-to
554
UT code for WoS article
000345332600004
EID of the result in the Scopus database
—